Radiopharmaceutical Market Size, Growth & Trends By 2033

Table Of Content

Executive Summary

Research Scope & Segmentation

Research Objectives
Limitations & Assumptions
Market Scope & Segmentation
Currency & Pricing Considered

Market Opportunity Assessment

Emerging Regions / Countries
Emerging Companies
Emerging Applications / End Use

Market Trends

Drivers
Market Warning Factors
Latest Macro Economic Indicators
Geopolitical Impact
Technology Factors

Market Assessment

Porters Five Forces Analysis
Value Chain Analysis

Regulatory Framework

North America
Europe
APAC
Middle East and Africa
LATAM

ESG Trends

Global Radiopharmaceutical Market Size Analysis

Global Radiopharmaceutical Market Introduction
By Radioisotopes Type
1. Introduction
  1. Radioisotopes Type By Value
2. Technetium 99
  1. By Value
3. Fluorine 18
  1. By Value
4. Iodine 131
  1. By Value
5. Lutetium 177
  1. By Value
6. Yttrium 90
  1. By Value
7. Radium-223
  1. By Value
8. Others
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Diagnostics
  1. By Value
3. Therapeutics
  1. By Value
By Source
1. Introduction
  1. Source By Value
2. Cyclotrons
  1. By Value
3. Nuclear Reactors
  1. By Value
4. Others
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Hospitals
  1. By Value
3. Medical Imaging Centers
  1. By Value
4. Cancer Research Institute
  1. By Value
5. Other
  1. By Value

North America Market Analysis

Introduction
By Radioisotopes Type
1. Introduction
  1. Radioisotopes Type By Value
2. Technetium 99
  1. By Value
3. Fluorine 18
  1. By Value
4. Iodine 131
  1. By Value
5. Lutetium 177
  1. By Value
6. Yttrium 90
  1. By Value
7. Radium-223
  1. By Value
8. Others
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Diagnostics
  1. By Value
3. Therapeutics
  1. By Value
By Source
1. Introduction
  1. Source By Value
2. Cyclotrons
  1. By Value
3. Nuclear Reactors
  1. By Value
4. Others
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Hospitals
  1. By Value
3. Medical Imaging Centers
  1. By Value
4. Cancer Research Institute
  1. By Value
5. Other
  1. By Value
U.S.
1. By Radioisotopes Type
  1. Introduction
    1. Radioisotopes Type By Value
  2. Technetium 99
    1. By Value
  3. Fluorine 18
    1. By Value
  4. Iodine 131
    1. By Value
  5. Lutetium 177
    1. By Value
  6. Yttrium 90
    1. By Value
  7. Radium-223
    1. By Value
  8. Others
    1. By Value
2. By Application
  1. Introduction
    1. Application By Value
  2. Diagnostics
    1. By Value
  3. Therapeutics
    1. By Value
3. By Source
  1. Introduction
    1. Source By Value
  2. Cyclotrons
    1. By Value
  3. Nuclear Reactors
    1. By Value
  4. Others
    1. By Value
4. By End-User
  1. Introduction
    1. End-User By Value
  2. Hospitals
    1. By Value
  3. Medical Imaging Centers
    1. By Value
  4. Cancer Research Institute
    1. By Value
  5. Other
    1. By Value
Canada

Europe Market Analysis

Introduction
By Radioisotopes Type
1. Introduction
  1. Radioisotopes Type By Value
2. Technetium 99
  1. By Value
3. Fluorine 18
  1. By Value
4. Iodine 131
  1. By Value
5. Lutetium 177
  1. By Value
6. Yttrium 90
  1. By Value
7. Radium-223
  1. By Value
8. Others
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Diagnostics
  1. By Value
3. Therapeutics
  1. By Value
By Source
1. Introduction
  1. Source By Value
2. Cyclotrons
  1. By Value
3. Nuclear Reactors
  1. By Value
4. Others
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Hospitals
  1. By Value
3. Medical Imaging Centers
  1. By Value
4. Cancer Research Institute
  1. By Value
5. Other
  1. By Value
U.K.
1. By Radioisotopes Type
  1. Introduction
    1. Radioisotopes Type By Value
  2. Technetium 99
    1. By Value
  3. Fluorine 18
    1. By Value
  4. Iodine 131
    1. By Value
  5. Lutetium 177
    1. By Value
  6. Yttrium 90
    1. By Value
  7. Radium-223
    1. By Value
  8. Others
    1. By Value
2. By Application
  1. Introduction
    1. Application By Value
  2. Diagnostics
    1. By Value
  3. Therapeutics
    1. By Value
3. By Source
  1. Introduction
    1. Source By Value
  2. Cyclotrons
    1. By Value
  3. Nuclear Reactors
    1. By Value
  4. Others
    1. By Value
4. By End-User
  1. Introduction
    1. End-User By Value
  2. Hospitals
    1. By Value
  3. Medical Imaging Centers
    1. By Value
  4. Cancer Research Institute
    1. By Value
  5. Other
    1. By Value
Germany
France
Spain
Italy
Russia
Nordic
Benelux
Rest of Europe

APAC Market Analysis

Introduction
By Radioisotopes Type
1. Introduction
  1. Radioisotopes Type By Value
2. Technetium 99
  1. By Value
3. Fluorine 18
  1. By Value
4. Iodine 131
  1. By Value
5. Lutetium 177
  1. By Value
6. Yttrium 90
  1. By Value
7. Radium-223
  1. By Value
8. Others
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Diagnostics
  1. By Value
3. Therapeutics
  1. By Value
By Source
1. Introduction
  1. Source By Value
2. Cyclotrons
  1. By Value
3. Nuclear Reactors
  1. By Value
4. Others
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Hospitals
  1. By Value
3. Medical Imaging Centers
  1. By Value
4. Cancer Research Institute
  1. By Value
5. Other
  1. By Value
China
1. By Radioisotopes Type
  1. Introduction
    1. Radioisotopes Type By Value
  2. Technetium 99
    1. By Value
  3. Fluorine 18
    1. By Value
  4. Iodine 131
    1. By Value
  5. Lutetium 177
    1. By Value
  6. Yttrium 90
    1. By Value
  7. Radium-223
    1. By Value
  8. Others
    1. By Value
2. By Application
  1. Introduction
    1. Application By Value
  2. Diagnostics
    1. By Value
  3. Therapeutics
    1. By Value
3. By Source
  1. Introduction
    1. Source By Value
  2. Cyclotrons
    1. By Value
  3. Nuclear Reactors
    1. By Value
  4. Others
    1. By Value
4. By End-User
  1. Introduction
    1. End-User By Value
  2. Hospitals
    1. By Value
  3. Medical Imaging Centers
    1. By Value
  4. Cancer Research Institute
    1. By Value
  5. Other
    1. By Value
Korea
Japan
India
Australia
Taiwan
South East Asia
Rest of Asia-Pacific

Middle East and Africa Market Analysis

Introduction
By Radioisotopes Type
1. Introduction
  1. Radioisotopes Type By Value
2. Technetium 99
  1. By Value
3. Fluorine 18
  1. By Value
4. Iodine 131
  1. By Value
5. Lutetium 177
  1. By Value
6. Yttrium 90
  1. By Value
7. Radium-223
  1. By Value
8. Others
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Diagnostics
  1. By Value
3. Therapeutics
  1. By Value
By Source
1. Introduction
  1. Source By Value
2. Cyclotrons
  1. By Value
3. Nuclear Reactors
  1. By Value
4. Others
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Hospitals
  1. By Value
3. Medical Imaging Centers
  1. By Value
4. Cancer Research Institute
  1. By Value
5. Other
  1. By Value
UAE
1. By Radioisotopes Type
  1. Introduction
    1. Radioisotopes Type By Value
  2. Technetium 99
    1. By Value
  3. Fluorine 18
    1. By Value
  4. Iodine 131
    1. By Value
  5. Lutetium 177
    1. By Value
  6. Yttrium 90
    1. By Value
  7. Radium-223
    1. By Value
  8. Others
    1. By Value
2. By Application
  1. Introduction
    1. Application By Value
  2. Diagnostics
    1. By Value
  3. Therapeutics
    1. By Value
3. By Source
  1. Introduction
    1. Source By Value
  2. Cyclotrons
    1. By Value
  3. Nuclear Reactors
    1. By Value
  4. Others
    1. By Value
4. By End-User
  1. Introduction
    1. End-User By Value
  2. Hospitals
    1. By Value
  3. Medical Imaging Centers
    1. By Value
  4. Cancer Research Institute
    1. By Value
  5. Other
    1. By Value
Turkey
Saudi Arabia
South Africa
Egypt
Nigeria
Rest of MEA

LATAM Market Analysis

Introduction
By Radioisotopes Type
1. Introduction
  1. Radioisotopes Type By Value
2. Technetium 99
  1. By Value
3. Fluorine 18
  1. By Value
4. Iodine 131
  1. By Value
5. Lutetium 177
  1. By Value
6. Yttrium 90
  1. By Value
7. Radium-223
  1. By Value
8. Others
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Diagnostics
  1. By Value
3. Therapeutics
  1. By Value
By Source
1. Introduction
  1. Source By Value
2. Cyclotrons
  1. By Value
3. Nuclear Reactors
  1. By Value
4. Others
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Hospitals
  1. By Value
3. Medical Imaging Centers
  1. By Value
4. Cancer Research Institute
  1. By Value
5. Other
  1. By Value
Brazil
1. By Radioisotopes Type
  1. Introduction
    1. Radioisotopes Type By Value
  2. Technetium 99
    1. By Value
  3. Fluorine 18
    1. By Value
  4. Iodine 131
    1. By Value
  5. Lutetium 177
    1. By Value
  6. Yttrium 90
    1. By Value
  7. Radium-223
    1. By Value
  8. Others
    1. By Value
2. By Application
  1. Introduction
    1. Application By Value
  2. Diagnostics
    1. By Value
  3. Therapeutics
    1. By Value
3. By Source
  1. Introduction
    1. Source By Value
  2. Cyclotrons
    1. By Value
  3. Nuclear Reactors
    1. By Value
  4. Others
    1. By Value
4. By End-User
  1. Introduction
    1. End-User By Value
  2. Hospitals
    1. By Value
  3. Medical Imaging Centers
    1. By Value
  4. Cancer Research Institute
    1. By Value
  5. Other
    1. By Value
Mexico
Argentina
Chile
Colombia
Rest of LATAM

Competitive Landscape

Radiopharmaceutical Market Share By Players
M&A Agreements & Collaboration Analysis

Market Players Assessment

PharmaLogic
1. Overview
2. Business Information
3. Revenue
4. ASP
5. SWOT Analysis
6. Recent Developments
Siemens Healthineers AG
Bracco
Cardinal Health
Bayer AG
IBA Radiopharma Solutions
Curium
Radiomedix
Eckert and Ziegler
NTP
Sinotau Pharmaceutical Group
Novartis AG
Eli Lilly and Company
Telix PharmaceuticalsLimited
NMR

Research Methodology

Research Data
1. Secondary Data
  1. Major secondary sources
  2. Key data from secondary sources
2. Primary Data
  1. Key data from primary sources
  2. Breakdown of primaries
3. Secondary And Primary Research
  1. Key industry insights
Market Size Estimation
1. Bottom-Up Approach
2. Top-Down Approach
3. Market Projection
Research Assumptions
1. Assumptions
Limitations
Risk Assessment